| abstract |
The present invention reduces and prevents the severity of stress-related symptoms in a subject by systemically administering an effective amount of brimonidine or a pharmaceutically acceptable salt, ester, amide, stereoisomer, or racemic mixture thereof. Provide a method. Stress-related symptoms treated by the methods of the present invention are not limited, but include dyspepsia; tachycardia except those associated with myocardial ischemia; non-inflammatory skin symptoms; muscle contraction disorders; migraine-related perception Hypersensitivity; and behavioral disorders. |